VisionVolve · Engage
Engagement Configuration Draft · Working document

Engagement Configuration Draft — Dr. Max — Day 0 (current reality)

For internal VV use, then negotiation with client. Working draft generated 2026-09-02 from current platform state. Edit freely; re-generate after major edits to platform state to refresh derived sections.

1. Executive summary

Client: Dr. Max — Day 0 (current reality)

Archetype: Elevation — Amplify an existing internal AI lead — capability exists but lacks authority, scope, or executional discipline. Partner extends, never replaces.

Duration: 6 months core engagement + 12 months long-tail compensation tail

Primary VV win: _[Anton to fill — reference engagement / methodology validation / pharma vertical entry / Penta relationship]_

Primary client win: _[Anton/Michal to fill — likely AI Act compliance + AI capability foundations + measurable operational benefits in 12 months]_

Indicative engagement value: €240K – €375K across 18 months (T1+T2+T3+T4 combined).

Today's diagnostic shape: 8 active obstacles, 5 carrying critical/large engagement-value-at-risk. Cumulative delay if unresolved: 34–84 weeks. Illustrative € exposure: €1.5M–€4.8M across 6 measured obstacles.

2. Engagement structure

This is not a typical outside-in consulting engagement. It is a co-leadership pattern for 6 months:

VV roles

Client-side counterparts

Unknown / open questions on counterparts:

Commercial responsibility split

3. Commercial structure

Four-tier compensation. Tiers are independent — each negotiated and invoiced separately to keep the structure clean.

T1 — Advisory time (CAIO + delivery rota)

Michal as Interim CAIO (1/4 FTE @ €2,000/day × 5 days/month = €10K/month) + Anton + 1–2 VV consultants on advisory rota (~20h/month @ €250/h = €5K/month). Capped monthly. Invoiced monthly against logged time.

T2 — Delivery scope (workshops + PoCs + analysis)

Workshops at €2,400/day (60K CZK/day) for facilitation + delivery; analysis, PoCs, reports invoiced separately at agreed rates. Indicative envelope of 6 workshops + 4–8 analysis pieces over 6 months. Budget capped at €120K with explicit scope ladder (must-have / should-have / nice-to-have).

T3 — Exit-criteria bonus (paid at M6)

€40K bonus paid at M6 if methodology-defined exit criteria satisfied. Each criterion independently observable. Weighted partial payout if subset achieved (e.g., 65% criteria met → €26K paid). Independently verifiable from platform state — no measurement debate.

Target: €40,000

Weighted criteria (sum = 100%):

WeightCriterion
20%Heavy Gate 2 fired ≥ once
15%AI Council met monthly for ≥ 4 consecutive months
20%Track 3 (AI OS) at L4 maturity
20%Track 5 (Risk & Compliance) at L4 maturity
15%AI conformity assessment (L3-329) operational
10%≥ 2 of 6 markets running cross-market sync forum

T4 — Benefits-realization tail (paid at M+6 and M+12 post-engagement)

Two long-tail compensation packages tied to measurable Dr-Max-side business benefits, paid 6 and 12 months after engagement closes. Designed jointly during M0–M2 with Kateřina + CFO Bornemann; specific metrics, baselines, targets, and bonus sizes locked at M2. Pre-condition: measurement plumbing for the chosen benefits must be operational by M3.

M6+6 months (≈ post-engagement Q2)

M6+12 months (≈ post-engagement Q4)

Total indicative engagement value (18-month horizon)

€240K – €375K

Note: the actual T2 and T4 sizes are negotiated. T1 is fixed-rate. T3 is fixed-target with weighted partial payout.

4. Authority asks for the Interim CAIO seat

These are the L1 partner authorities Michal needs to function as Interim CAIO. Methodology defaults for Elevation engagements are filtered below; current state has all 32 set to Out (Day-0 baseline).

Must-have (engagement cannot deliver without)

Information:

Hiring:

Communication:

5. Mechanisms to install

L3 mechanisms (forums, gates, escalation paths, protocols, cadences, artifacts) the engagement stands up over 6 months. Currently none stood up at Dr Max for AI specifically.

Forum (11)

Gate (4)

ArtifactEvent (3)

Path (4)

Protocol (6)

Cadence (1)

Artifact (1)

6. Exit criteria — what "engagement complete" means

Tied to T3 bonus (Section 3). Independently observable from platform state at M6.

Methodology exit criteria reference: methodology/exit-criteria.json defines 8 hard criteria + 5 soft; the ones above are a curated subset weighted for this archetype + scope.

7. Long-term benefits to design with Kateřina + CFO

These are placeholders. Specific benefit pairing, baselines, targets, and bonus sizes are co-designed with Kateřina + Thomas Bornemann (CFO) during M0–M2 and locked at M2.

Candidate operational benefits for Dr Max (to validate)

Pre-condition before commercial commitment to T4 packages

Measurement plumbing (data pipelines, baselines, monthly reporting cadence) must be operational by M3 for any benefit selected for T4 compensation. If plumbing isn't ready by M3 for a candidate benefit, it cannot anchor a T4 package — drop it and pick another.

8. Known risks (active obstacles + recovery)

Top 5 active obstacles in current diagnostic. Each has methodology-defined recovery actions.

O-001 — Pipeline Stall at Gate 2 [severity: high]

Initiatives accumulate at Pilot-Validated; Scale decisions don't happen

Impact: 4–8 weeks delay · MEDIUM VaR · schedule / cost / scope

Initiatives accumulate at Pilot-Validated; pilot budgets are spent without scale-up commitment. Engagement loses credibility within 60 days as the Sponsor sees outputs but no decisions.

Recovery actions during engagement:

O-003 — Risk Function Disengaged [severity: high]

Regulated profile but CRO/DPO not integrated; risk classification skipped

Impact: 8–16 weeks delay · LARGE VaR · compliance / relationship / schedule

Risk classifications skipped; one bad initiative kicks off and blows up audit/regulatory window. Pharma-high regulatory profile makes this catastrophic — potential SUKL / EMA exposure.

Recovery actions during engagement:

O-008 — VV Commercial Capture [severity: high]

Recusal protocol breached; Partner advocates for VV scope expansion; ethics violation

Impact: 0–4 weeks delay · CRITICAL VaR · relationship / scope

Recusal protocol breached; Partner advocates for VV scope expansion; ethics violation. Potential to be told to leave the engagement entirely.

Recovery actions during engagement:

O-010 — Heavy-Gate Decision Drift [severity: high]

Forums standing but not deciding; gates become advisory; portfolio prioritization becomes politics

Impact: 4–12 weeks delay · LARGE VaR · schedule / quality

Forums standing but not deciding; gates become advisory; portfolio prioritization becomes politics. Engagement output quality drops as the methodology is used for theatre.

Recovery actions during engagement:

O-013 — Sponsor Escalation Stalled [severity: high]

Engagement begins with a sub-C-suite sponsor; CEO never engages substantively; engagement stays advisory and never reaches structural authority

Impact: 8–20 weeks delay · LARGE VaR · scope / relationship / schedule

Engagement begins with sub-C-suite sponsor; CEO never engages substantively; engagement stays advisory and never reaches structural authority. Outcomes degrade to slide-decks.

Recovery actions during engagement:

9. Open questions to validate with client

Items below need direct confirmation from Kateřina or Leo before final engagement commitment.

10. Proposed sequencing (next 4–6 weeks)

1. 7 high-severity obstacles firing — engagement risk profile is elevated

2. Pre-stage 30-min CEO briefing before M0

3. Stand up L3-329 (AI conformity assessment process) within 30 days

4. Negotiate 3 authorities during M0

5. Charter cross-market sync forum (L3-326)

6. Confirm Luca Demarchi still in seat (or identify successor)


Draft generated by VV Engage. Methodology v0.2.1 · Engine v0.2 · Recommendations v0.1 · Engagement structure: Interim Senior Role.

Edit freely. Re-generate after material edits to platform state to refresh derived sections (sections 1, 4, 5, 8, 10).